VADAX
Price
$73.26
Change
+$0.62 (+0.85%)
Updated
Jun 6 closing price
Net Assets
6.65B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

VADAX vs VITSX

Header iconVADAX vs VITSX Comparison
Open Charts VADAX vs VITSXBanner chart's image
Invesco Equally-Wtd S&P 500 A
Price$73.26
Change+$0.62 (+0.85%)
VolumeN/A
Net Assets6.65B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
VADAX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VADAX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VADAX is a StrongBuy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. VADAX (6.66B). VADAX (1.32) and VITSX (1.29) have matching dividends . VADAX was incepted earlier than VITSX: VADAX (28 years) vs VITSX (28 years). VADAX (0.53) is less costly to investors than VITSX (0.03). VADAX is a more actively managed with annual turnover of: 22.00 vs. VITSX (2.00). VADAX has a lower initial minimum investment than VITSX: VADAX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. VADAX (1.53). VITSX return over 5 years is better than : 80.96 vs. VADAX (25.20).
VADAXVITSXVADAX / VITSX
Total Expense Ratio0.530.031,767%
Annual Report Gross Expense Ratio0.530.031,767%
Fund Existence28 years28 years-
Gain YTD1.4810.833178%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.66B1.82T0%
Annual Yield % from dividends1.321.29102%
Returns for 1 year1.5310.9714%
Returns for 3 years3.9040.3510%
Returns for 5 years25.2080.9631%
Returns for 10 years61.27180.4934%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.